Melatonin protects against lipid peroxidation induced by δ- aminolevulinic acid in rat cerebellum, cortex and hippocampus

Neuroscience

Volumn 82, Issue 1, 1997, Pages 293-299

  Carneiro, R C G ^a   Reiter, R J ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Brain; Free radicals; In vitro; In vivo; Melatonin; Porphyria

Indexed keywords

ALPHA TOCOPHEROL; AMINOLEVULINIC ACID; HYDROXYALDEHYDE; MALONALDEHYDE; MELATONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

AMINOLEVULINIC ACID; ANIMALS; ANTIOXIDANTS; CEREBELLUM; CEREBRAL CORTEX; HIPPOCAMPUS; INDICATORS AND REAGENTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MELATONIN; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 0030929407     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(97)00262-5     Document Type: Article

References (48)

1. Arendt J. Melatonin. Clin. Endocr. 29:1988;205-229.
2. Armstrong S. M. and Redman J. (1985) Melatonin administration: effects on rodent circadian rhythms. In Photoperiodism, Melatonin and the Pineal (eds Evered D. and Clark S.), Ciba Foundation Symposium 117, pp. 188-207. Pitman Publishing, London.
3. Becker D., Viljoen D., Kramer S. The inhibition of red cell and brain ATP-ase by δ-aminolevulinic acid. Biochim. biophys. Acta. 225:1971;26-34.
4. Bornstein J. C., Picket J. B., Diamond I. Inhibition of the evoked release of acethylcholine by the porphyrin precursor δ-aminolevulinic acid. Ann. Neurol. 5:1979;94-96.
5. Bradford M. A rapid and sensitive method for quantification of protein utilizing the principle of protein dye binding. Analyt. Biochem. 72:1976;248-253.
6. Chan T. Y., Tang P. L. Characterization of the antioxidant effects of melatonin and related indoleamines in vitro. J. Pineal Res. 20:1996;187-191.
7. Ciuffi M., Gentilini G., Franchi-Micheli S., Zilletti L. Lipid peroxidation induced "in vivo" by iron-carbohydrate complex in the rat brain cortex. Neurochem. Res. 16:1991;43-49.
8. Esterbauer H., Cheeseman K. H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynomenal. Meth. Enzym. 186:1990;407-421.
9. Feldman D. S., Levere R. D., Lieberman J. S. Presynaptic neuromuscular inhibition by delta-aminolevulinic acid, a porphyrin precursor. Trans. Am. neurol. Ass. 93:1968;206-208.
10. Feldman D. S., Levere R. D., Lieberman J. S., Cardinal R. A., Watsom C. J. Presynaptic neuromuscular inhibition by porphobilinogen and porphobilin. Proc. natn. Acad. Sci. U.S.A. 68:1971;383-386.
11. Granick S., Vanden Schriek H. G. Porphobilinogen and delta-aminolevulinic acid in acute porphyria. Proc. Soc. exp. Biol. Med. 88:1955;270-273.
12. Halliwell B. Reactive oxygen species and the central nervous system. Short review. J. Neurochem. 59:1992;1609-1623.
13. Hardeland R., Balzer I., Poeggeler B., Fuhrberg B., Uria H., Behrmann G., Wolf R., Meyer T. J., Reiter R. J. On the primary functions of melatonin in evolution: Mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J. Pineal Res. 18:1995;104-111.
14. Hindmarsh J. T. The porphyrias: recent advances. Clin. Chem. 32:1986;1255-1263.
15. Juknat A. A., Kotler M. L., del Carmen Batlle A. M. High δ-aminolevulinic acid uptake in rat cerebral cortex: effect on porphyrin biosynthesis. Comp. Biochem. Physiol. 11:1995;143-150.
16. Kappas A., Sassa S., Galbraith R. A. and Nordmann Y. (1989) The Metabolic Basis of Inherited Diseases. pp. 1305-1365. McGraw Hill, New York.
17. Loots J. M., Becker D. M., Meyer B. J., Goldstuck N., Kramer S. The effect of porphyrin precursors on monosynaptic reflex activity in the isolated hemisected frog spinal cord. J. neural. Transm. 36:1975;71-81.
18. McGillion F. B., Thompson G. G., Goldberg A. Tissue uptake of δ-aminolevulinic acid. Biochem. Pharmac. 24:1975;299-301.
19. Medeiros M. H. G., Marchiori P. E., Bechara E. J. H. Superoxide dismutase, glutathione peroxidase and catalase activities in the erythrocytes of patients with intermittent acute porphyria. Clin. Chem. 28:1982;242-243.
20. Melchiorri D., Reiter R. J., Attia A. M., Hara M., Burgos A., Nistico G. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci. 56:1995;83-89.
21. Menendez-Pelaéz A., Reiter R. J. Distribution of melatonin in mammalian tissues: relative importance of nuclear verses cytosolic localization. J. Pineal Res. 15:1993;56-69.
22. Menendez-Pelaéz A., Poeggeler B., Reiter R. J., Barlow-Walden L. R., Pablos M. I., Tan D. X. Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J. Cell Biochem. 53:1993;372-382.
23. Monteiro H. P., Abdalla D. S. P., Faljoni-Alario A., Bechara E. J. H. Generation of active oxygen species during coupled autoxidation of oxyhemoglobin and delta-aminolevulinic acid. Biochim. biophys. Acta. 881:1986;100-106.
24. Monteiro H. P., Abdalla D. S. P., Augusto O., Bechara E. J. H. Free radical generation during delta-aminolevulinic acid autoxidation induction by hemoglobin and connections with porphyrinpathies. Archs Biochem. Biophys. 271:1989;206-216.
25. Monteiro H. P., Bechara E. J. H., Abdalla D. S. P. Free radicals involvement in neurological porphyrias and lead poisoning. Molec. cell. Biochem. 103:1991;73-83.
26. 2+ ions. Biochim. biophys. Acta. 1225:1994;259-263.
27. Oteiza P. I., Bechara E. J. H. 5-aminolevulinic acid induces lipid peroxidation in cardiolipin-rich lipossomes. Archs Biochem. Biophys. 305:1993;282-287.
28. Percy V. A., Shanley B. C. Porphyrin precursors in blood, urine and cerebrospinal fluid in acute porphyria. S. Afr. med. J. 52:1977;219-222.
29. Pieri C., Marra M., Moroni F., Recchioni R., Marcheselli F. Melatonin: a peroxyl radical scavenger more effective than vitamin E. Life Sci. 55:1994;PL271-PL276.
30. Princ F. G., Juknat A. A., del C. Batlle A. M. Porphyrinogenesis in rat cerebellum. Effect of high δ-aminolevulinic acid concentration. Gen. Pharmac. 25:1994;761-766.
31. Puy H., Deybach J. C., Baudry P., Callebert J., Touitou Y., Nordmann Y. Decreased nocturnal plasma melatonin levels in patients with recurrent acute intermittent porphyria attacks. Life Sci. 53:1993;621-627.
32. Puy H., Deybach J. C., Bogdan A., Callebert J., Baumgartner M., Voisin P., Nordmann Y., Touitou Y. Increased δ-aminolevulenic acid and decreased melatonin production. J. clin. Invest. 97:1996;104-110.
33. Reiter R. J. The pineal and its hormones in the regulation of reproduction in mammals. Endocr. Rev. 1:1980;109-131.
34. Reiter R. J. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr. Rev. 12:1991;151-180.
35. Reiter R. J. Functional aspects of the pineal hormone melatonin in combating the tissue damage induced by free radicals. Eur. J. Endocr. 134:1996;413-420.
36. Reiter R. J., Melchiorri D., Sewerynek E., Poeggeler B., Barlow-Walden L. R., Chuong J. I., Ortiz G. G., Acuña-Castroviejo D. A review of the evidence supporting melatonin's role as an antioxidant. J. Pineal Res. 18:1995;1-11.
37. +-ATPase activity by δ-aminolevulinic acid. Neurochem. Res. 8:1983;1407-1415.
38. Sassa S., Kappas A. Genetic, metabolic and biochemical aspects of the porphyrias. Adv. Hum. Genet. 11:1981;121-231.
39. Scaiano J. C. Exploratory laser flash photolysis study of the radical reactions and magnetic field effects in melatonin chemistry. J. Pineal Res. 19:1995;189-195.
40. Shanley B. C., Neethling A. C., Percy V. A., Carstens M. Neurochemical aspects of porphyria. Studies on the possible neurotoxicity of delta-aminolevulinic acid. S. Afr. med. J. 49:1975;576-580.
41. Shida C. S., Castrucci A. M. L., Lamy-Feund M. T. High solubility of melatonin in aqueous medium. J. Pineal Res. 16:1994;198-201.
42. Sweeney V. P., Pathak M. A., Ashbury A. K. Acute intermittent porphyria; increased ALA-synthetase activity during an acute attack. Brain. 93:1970;369-380.
43. Tan D. X., Chen L. D., Poeggeler B., Manchester L. C., Reiter R. J. Melatonin: a potent, endogenous hydroxyl radical scavenge. Endocr. J. 1:1993;57-60.
44. Tan D. X., Poeggeler B., Reiter R. J., Chen L. D., Chen S., Manchester L. C., Barlow-Walden L. R. The pineal hormone melatonin inhibits DNA adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett. 70:1993;65-71.
45. Tan D. X., Reiter R. J., Chen L. D., Poeggeler B., Manchester L. C., Barlow-Walden L. R. Both physiological and pharmacological levels of melatonin reduce DNA adduct formation induced by the chemical carcinogen safrole. Carcinogenesis. 15:1994;215-218.
46. 2+ and membrane protein thiols. Biochim. biophys. Acta. 1188:1994;86-92.
47. Vijayalaxmi, Reiter R. J., Sewerynek E., Poeggeler B., Leal B. Z., Meltz M. L. Marked reduction of radiation-induced micronuclei in human blood lymphocytes pretreated with melatonin. Radiat. Res. 143:1995;102-106.
48. Yu B. P. Cellular defenses against damage from reactive oxygen species. Physiol. Rev. 74:1994;139-162.